Menu Close

Experimental compound displays effectiveness in treating symptoms of Autism and Alzheimer’s disease

An extensive international study led by Tel Aviv University found that an experimental drug which has been awarded orphan drug designation by the FDA for future treatment of a rare development disorder can also treat a variety of symptoms relating to autism, intellectual disability, and Alzheimer’s disease.